P28907 (CD38_HUMAN) Homo sapiens (Human)

ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 UniProtKBInterProSTRINGInteractive Modelling

300 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

47 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A Heteromer
46-300
EDO;CL;NA;MG;
Assess
crystal structure of CD38 in complex with daratumumab Heteromer
48-300
Assess
human CD38 in complex with nanobody MU375 Heteromer
49-300
SO4;GOL;
Assess
human CD38 in complex with nanobody MU551 Heteromer
49-296
Assess
human CD38 in complex with nanobody MU1053 Heteromer
49-296
Assess
Crystal structure of CD38 with a novel CD38-targeting antibody SAR650984 Heteromer
48-287
Assess
Crystal structure of human CD38 in complex with the Fab fragment of antibody HB7 Heteromer
50-279
Assess
Crystal structure of daratumumab fab and CD38 complex Heteromer
57-285
Assess
Human CD38 ectodomain bound to a 78c-ADPR adducthomo-2-mer45-283
Q2C;
Assess
X-ray structure of human CD38 catalytic domain with 2'-Cl-araNAD+monomer46-300
ROJ;K;PO4;PEG;MPD;PGE;
Assess
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
CXR;
Assess
Crystal structure of human CD38 extracellular domain, GTP complexmonomer45-296
GTP;
Assess
Crystal structure of human CD38 extracellular domain, ara-F-ribose-5'-phosphate/nicotinamide complexmonomer45-296
RF5;NCA;
Assess
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
CGR;
Assess
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysismonomer45-296
G1R;
Assess
Catalysis associated conformational changes revealed by human cd38 complexed with a non-hydrolyzabl…monomer45-296
N1C;
Assess
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysismonomer45-296
APR;
Assess
Crystal structure of human CD38 extracellular domain, ribose-5'-phosphate intermediate/GTP complexmonomer45-296
RGT;
Assess
Crystal structure of human CD38 complexed with an analog ara-2'F-ADPRmonomer45-296
AVU;
Assess
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
CXR;
Assess
Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolyzabl…monomer45-296
N1C;
Assess
Crystal structure of human CD38 extracellular domain, NMN complexmonomer45-296
NMN;
Assess
Crystal structure of human CD38 extracellular domain E226Q mutant, NMN complexmonomer45-296
NMN;
Assess
Crystal structure of human CD38 extracellular domainmonomer45-296
Assess
Crystal structure of human CD38 in complex with compound CZ-50bmonomer45-296
50A;NCA;
Assess
Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine NAAPD synthesis and h…monomer45-296
NMN;
Assess
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
CXR;
Assess
Crystal structure of human CD38 complexed with an analog ribo-2'F-ADP ribosemonomer45-296
AVW;
Assess
Crystal structure of human CD38 extracellular domain complexed with a covalent intermediate, ara-F-…monomer45-296
RF5;
Assess
Crystal structure of human CD38 in complex with compound CZ-48monomer45-296
48Z;
Assess
Crystal structure of human CD38 in complex with compound CZ-46monomer45-296
46Z;
Assess
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
NGD;
Assess
CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose templatemonomer45-296
CVR;
Assess
Crystal structure of human CD38: cyclic-ADP-ribosyl synthetase/NAD+ glycohydrolasemonomer46-297
SO4;
Assess
Crystal structure of human CD38 in complex with compound CZ-27monomer46-296
27C;
Assess
Crystal structure of human CD38 E226Q mutant in complex with NAADPmonomer46-296
DN4;
Assess
CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose templatemonomer48-296
C8R;
Assess
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysismonomer48-296
NAD;
Assess
Structure of a human CD38 mutant complexed with NMNmonomer46-293
NMN;
Assess
Crystal Structure of Human CD38 in Complex with 4'-Thioribose NAD+monomer45-292
ZNA;
Assess
Crystal structure of human CD38 in complex with hydrolysed compound JMS713monomer50-296
JS2;
Assess
Crystal structure of the extracellular domain of human CD38monomer45-291
EPE;
Assess
Crystal structure of wild type human CD38 in complex with NAADP and ADPRPmonomer46-291
DVN;
Assess
Human CD38 complexed with inhibitor 2 [4-[(2,6-dimethylbenzyl)amino]-2-methylquinoline-8-carboxamid…monomer46-290
41Z;NA7;
Assess
Human CD38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-…monomer46-288
733;HSX;
Assess
Dynamic conformations of the CD38-mediated NAD cyclization captured using multi-copy crystallographymonomer46-281
AVU;
Assess
Conformational Closure of the Catalytic Site of Human CD38 Induced by Calciummonomer45-279
CA;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6vua.1.Amonomer0.8846-300
K;98.44
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26vua.1.Amonomer0.6746-121
98.70
Assess